Member Info for MaverickD

Its a chase for shares - can't anyone see the massive buys that have been filled - will expect this to now head higher and 8p+ likely. MMs have played this and the retail investors have been picked off.

Time to load up!!

No they are buys lol - mms have taken the price down to fill the orders

Two 3m buys have just been worked through - explains what the MMS have been filling

I have added again at 14.9p - can't not help buy as we await our anticipated update with Avion.
Eureka progress should also be posted, albeit that may happen during the AGM.

I am waiting to add, but I am waiting to see if 22.5p acts as a support. Better to hold some and then add, which is what I have done, but I think we could see a lower entry around 1-2pm

I'm glad someone can read.......MMs drove down the bid to shake out a few. Perhaps margin traders got stung here as there would have been a number long with Brent having been moving up for the last fortnight.

They brought it low to take out the stops and now you can see the massive buys filling. Sometimes you are better switching off the machine than selling and crystallising losses. I was sitting on the sidelines having sold at 12p and now have a great re-entry.

Yes but some have been mugged off - they are gradually bring production higher to get to the optimum level! Back up to 10p - watch

Bargain basement love it

I did say it, so waiting for 22.5 to be tested

In a word no I don't think we will......we will know in 3 mins

Nolupus that made me laugh - LT equating time days. Well I guess we will wait and see what the next few weeks brings - I believe it will be transformational. Good Luck All - Health first, wealth second

Feel we will see pressure on the SP due to the overall market being down - ftse called lower, although tomorrow could see the bottom in. It was encouraging it did not re-test 22.5, but I have money set aside if the mms have a nibble at it tomorrow.

Oh now Oil won't play ball!

We are positive I knew this would bounce......going to finish high!!!

Looks like we could be on the cusp of this finally breaking out of this range

Looks like those 2 trades have held this back whilst filled......I think we have quite a bit of ground to make up with Enquest up and PMO in the blue. I am thinking a very strong finish today

Ok the sp pre trial was over £1.50 this was in 2018 and it fell afterwards to around 35p. It then traded down towards the 10p mark, but we know that the cohort that made up the sample for the testing showed no side effects and in some instances they showed positive signs following treatment. Think there were about 60 as part of the cohort. 'Primary endpoint successfully met from the open label extension study evaluating safety and tolerability from the Pivotal Phase III trial of Lupuzor™ in patients with Systemic Lupus Erythematosus'

A deal was signed with Avion in November 2019 Avion who will fund the full expected costs of the new Phase III trial up to $25 million. ImmuPharma will receive milestone payments of up to $70 million. A $5 million milestone payment will be paid on regulatory approval of Lupuzor™ in lupus, and $65 million will be based on achievement of overall sales targets. This news took the sp back upto around 32p. This is now acts as an upper resistance.

We had an update in Feb 2020 advising of a meeting with Avion and FDA in Q1 2020 (April - June) that will confirm next steps, but also suggested potential commercial opportunities.

Last Thursday the update advised 'that part of an overall evaluation of how we might apply our patented technologies to the fight against the Covid-19 epidemic, within our 'Autoimmunity' therapy area, we have also been considering the unique way that Lupuzor ™ interacts with the immune system and any potential application to Covid-19.'

Today we had confirmation that the AGM will take place on 18/6 and my view is that the meeting with Avion will take place before then.

100% from here more than likely, however depending on improving news flow of course £1 is possible. Have you not seen how much money the US have paid Astra (£1.2B) for development of a cure for CV - this is happening around the world. If there is any potential to use our pipeline to treat or improve chances of survival in patients with CV is it not completely plausible that money could be invested here, not only by Avion but other Pharma companies?

See you back on Wednesday